Document and Entity Information [Abstract]
Document and Entity Information [Abstract]
Statement [Table]
Legal Entity [Axis]
Entity [Domain]
Statement [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Period End Date
Trading Symbol
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Entity Filer Category
Entity Common Stock, Shares Outstanding
Entity Current Reporting Status
Entity Voluntary Filers
Entity Well Known Seasoned Issuer
Entity Public Float
Document Fiscal Year Focus
Document Fiscal Period Focus
Statement of Financial Position [Abstract]
ASSETS
Current Assets
Cash and cash equivalents
Marketable securities
Restricted cash
Accounts receivable - project revenue and reimbursable project costs
Prepaid expenses and other current assets
Total Current Assets
Property Plant and Equipment -net
Other Assets
Patent costs
Total Assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable and accrued liabilities
Total Current Liabilities
Warrant liability
Total Liabilities
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding
Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding and 15,057,243 shares outstanding at December 31, 2014 and December 31, 2013, respectively
Additional paid-in capital
Accumulated Deficit
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity
Preferred Stock, Par Value Per Share
Preferred Stock, Shares Authorized
Preferred Stock, Shares Issued
Preferred Stock, Shares Outstanding
Common Stock, Par Value Per Share
Common Stock, Shares Authorized
Common Stock, Shares, Issued
Common Stock, Shares, Outstanding
Statement of Operations [Abstract]
Revenue:
Consulting Revenue
Cost of Consulting Services Provided
Gross Margin
Operating Expenses
General and administrative
Research and development expenses
Total Operating Expenses
Operating Loss
Other Income and (Expenses)
Warrant revaluation
Warrant revaluation
Investment income
Other income (expenses)
Total Other Income and (Expenses)
Net loss before income taxes
Income taxes
Net loss
Net Loss Per Common Share, Basic and Diluted
Weighted Average Number of Shares Outstanding
Statement of Cash Flows [Abstract]
Operating Activities:
Net Loss
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Loss on marketable securities
Warrant revaluation
Changes in non-cash operating working capital items:
Accounts receivable - fees and reimbursable project costs
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Net Cash Used In Operating Activities
Investing Activities:
Proceeds from the sale of marketable securities
Payments for Patent costs
Net Cash Provided by (Used In) Investing Activities
Financing Activities:
Net proceeds from the issuance of common stock
Payments for Stock offering costs
Restricted cash
Net Cash Provided by Financing Activities
Net Increase In Cash and Cash Equivalents
Cash and Cash Equivalents, Beginning of Year
Cash and Cash Equivalents, End of Year
Supplemental Disclosure of Cash Flow Information:
Cash paid during the year:
Cash paid during the year:
Interest paid
Income taxes paid
Non-Cash Financing Activity:
Warrant liability - fair value of warrants exercised
Warrant liability fair value of warrants exercised
Equity Components [Axis]
Equity Components [Domain]
Common Stock [Member]
Additional Paid-In Capital [Member]
Deficit [Member]
Stock Commited Future Issuance [Member]
Stock Commited Future Issuance [Member]
Statement of Stockholders Equity [Abstract]
Beginning Balance
Beginning Balance (Shares)
Shares Issued (Shares)
Proceeds from the sale of common stock - net of offering costs
Proceeds from the sale of common stock - net of offering costs
Proceeds from the sale of common stock - net of offering costs (Shares)
Proceeds from the sale of common stock - net of offering costs (Shares)
Shares Issued (Shares) (SharesIssued)
Shares issued - registered offerings and stock grants
Shares issued - registered offerings and stock grants
Shares issued - registered offerings and stock grants (Shares)
Shares issued - registered offerings and stock grants (Shares)
Fair value of warrants issued with financing
Stock-based compensation
Stock-based compensation (Shares)
Warrants exercised
Warrants exercised
Warrants exercised (Shares)
Warrants exercised (Shares)
Net loss
Stock-based compensation and payment of accrued compensation
Stock-based compensation and payment of accrued compensation
Stock-based compensation and payment of accrued compensation (Shares)
Stock-based compensation and payment of accrued compensation (Shares)
Ending Balance
Ending Balance (Shares)
Notes to Financial Statements [Abstract]
Notes to Financial Statements [Abstract]
Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations [Text Block]
Restatement of Financial Statements [Text Block]
Restatement of Financial Statements
Net Loss Per Share [Text Block]
Scenario [Axis]
Scenario [Domain]
Approximations [Member]
Approximations
As Previously Reported [Member]
Accounts Receivable -Project Revenue and Reimbursable Project Costs [Text Block]
Prepaid Expenses & Other Current Assets [Text Block]
Prepaid Expenses & Other Current Assets [Text Block]
Patents and Other Assets [Text Block]
Accounts Payable and Accrued Liabilities [Text Block]
Valuation Allowance by Deferred Tax Asset [Axis]
Deferred Tax Asset [Domain]
Deferred Tax Asset Amount [Member]
Deferred Tax Asset Amount
Income Taxes [Text Block]
Warrant Liability [Text Block]
Commitments and Contingencies [Text Block]
Research and Development Costs [Text Block]
Stockholders' Equity [Text Block]
Business Segment Results [Text Block]
Fair Value Measurements [Text Block]
Basis of Consolidation [Policy Text Block]
BasisOfPresentation
Use of Estimates and Assumptions [Policy Text Block]
Significant Estimates [Policy Text Block]
Significant Estimates
Company Liquidity, Certain Risks, Uncertainties and Concentrations [Policy Text Block]
Revenue Recognition [Policy Text Block]
Stock-Based Compensation [Policy Text Block]
Fair Value of Financial Instruments [Policy Text Block]
Cash and Cash Equivalents and Restricted Cash and Marketable Securities [Policy Text Block]
Trade Accounts Receivable [Policy Text Block]
Income Taxes [Policy Text Block]
Foreign Currency [Policy Text Block]
Patents and Legal Costs [Policy Text Block]
Impairment of long-lived assets [Policy Text Block]
Research, Development and Related Expenses [Policy Text Block]
Segment Reporting [Policy Text Block]
Commitments and Contingencies [Policy Text Block]
Warrant Liability [Policy Text Block]
Recent Accounting Pronouncements [Policy Text Block]
Property, Plant and Equipment [Policy Text Block]
Retirement 401(K) Plan [Policy Text Block]
Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]
Basis of presentation [Policy Text Block]
Consulting Business Segment [Policy Text Block]
Consulting Business Segment
Technology Business Segment [Policy Text Block]
Technology Business Segment
Schedule of Outstanding Warrants, Restatement [Table Text Block]
Schedule of Outstanding Warrants, Restatement
Schedule of Consolidated Statement of Operations, Restated [Table Text Block]
Schedule of Consolidated Statement of Operations, Restated [Table Text Block]
Schedule of Consolidated Balance Sheet, Restated [Table Text Block]
Schedule of Consolidated Balance Sheet, Restated
Schedule of Consolidated Cash Flows, Restated [Table Text Block]
Schedule of Consolidated Cash Flows, Restated
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule of Reconcilation of Income Taxes (Benefit) [Table Text Block]
Schedule of Aggregate Fair Values, Warrants [Table Text Block]
Schedule of Warrants Outstanding [Table Text Block]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of Fair Value, Financial Assets and Liabilities [Table Text Block]
Schedule of Reconciliation of Warrant Liability [Table Text Block]
Financial Instrument [Axis]
Financial Instruments [Domain]
Doubleline Total Return Bond Fund [Member]
Doubleline Total Return Bond Fund
Vanguard Wellesley Income Fund [Member]
Vanguard Wellesley Income Fund
Vanguard High Yield Corp Investor Fund [Member]
Vanguard High Yield Corp Investor Fund
Vanguard GNMA Investor Fund [Member]
Vanguard GNMA Investor Fund
Vanguard Short Term Investment Grade Investor [Member]
Vanguard Short Term Investment Grade Investor
Adjustment [Member]
As Restated [Member]
Range [Axis]
Range [Domain]
Minimum [Member]
Maximum [Member]
Remainder [Member]
Remainder
Adjustments [Member]
Adjustments
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Domain]
Corporate Credit Card and Daily ACH Transaction Limit [Member]
Corporate Credit Card and Daily ACH Transaction Limit
Major Customers [Axis]
Name of Major Customer [Domain]
ENEC and FANR Projects [Member]
ENEC Project
FANR [Member]
FANR
Lloyd Register Contract [Member]
Lloyd Register Contract
ENEC [Member]
ENEC
Customer Contract [Member]
Value of nuclear science and technology center
Value of nuclear science and technology center
Extention of fuel cycle length
Extention of fuel cycle length
Power output increase based on future potential reveunes
Power output increase based on future potential reveunes
Operating cycle length
Operating cycle length
Maximum increase in power output
Maximum increase in power output
Metallic fuel power uprate percentage
Metallic fuel power uprate percentage
Operating cycle length - Westinghouse-type
Operating cycle length - Westinghouse-type
Stock based compensation
Federally insured cash limit
Cash and Cash Equivalents, at Carrying Value
Restricted Cash
Letters of credit outstanding
Letters of credit outstanding
Marketable Securities
Mutual Funds
Unrealized Gain (Loss) on Securities
Cost basis of investments
Unrealized gain loss from financial institutions
Unrealized gain loss from financial institutions
Valuation allowance
Valuation allowance
More likely than not threshold
More likely than not threshold
Percentage of cost of consulting from one firm
Percentage of cost of consulting from one firm
Concentration Risk, Percentage
Amortization period for patents
Research and Development Expense
Additional paid-in capital
Accumulated deficit
Stockholders' Equity
Cumulative effect
Cumulative effect
Accounts Receivable
Portion of accounts receivable
Portion of accounts receivable
Major customer revenue percentage
Major customer revenue percentage
Unbilled receivable
Foreign Currency Transaction Gain (Loss)
Travel costs and reimbursable costs
Travel and other reimbursable expenses included in accounts receivable
Travel and other reimbursable expenses included in accounts receivable
Prepaid Expense and Other Assets, Current
Security Deposit
Estimated useful life of patents and other intangible assets
Capitalized costs for patents
Capitalized costs for patents
Investment in patents
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate
Deferred Tax Assets, Operating Loss Carryforwards
Valuation allowance
Change in valuation allowance
Non-cash income
Lease agreement [Axis]
Lease agreement
Lease agreement [Domain]
Lease agreement
Moscow Office [Member]
Moscow Office
Virginia Office [Member]
Virginia Office
Litigation Case [Axis]
Litigation Case [Domain]
Fairfax County Complaint 1 [Member]
Fairfax County Complaint 1
Fairfax County Complaint 2 [Member]
Fairfax County Complaint 2
Operating lease term
Operating lease term
Monthly rental fees
Deferred rent liability
Rent expense
Compensatory damages sought
Research and Development Agreement [Axis]
Research and Development Agreement [Domain]
Task Order No.1 with Texas AM University [Member]
Task Order 1 with Texas AM University
Research and development costs
Research and development costs
Consulting agreement monthly payments
Consulting agreement monthly payments
Amount due upon execution
Amount due upon execution
Amount due on December 15, 2012
Total amount of payments made
Amount due on delivery of the final report
Professional Services Agreement
Award Type [Axis]
Award Type [Domain]
Stock Compensation Plan [Member]
Maximum restricted shares granted [Member]
Maximum restricted shares granted [Member]
Maximum number of shares in respect to stock options [Member]
Maximum number of shares in respect to stock options [Member]
Maximum restricted shares granted to one person [Member]
Maximum restricted shares granted to one person [Member]
Stock Options Vested [Member]
Stock Options Vested
Stock-based compensation [Member]
Stock-based compensation [Member]
Restricted Stock [Member]
Restricted Stock Units [Member]
Warrants [Member]
Employee Stock Option [Member]
Stock and Stock Equivalents [Member]
Stock and Stock Equivalents
Option [Member]
2006 Stock Plan [Member]
2006 Stock Plan
2015 Equity Incentive Plan [Member]
2015 Equity Incentive Plan
Equity Transaction [Axis]
Equity Transaction [Axis]
Equity Transaction [Domain]
Equity Transaction [Domain]
Issuance of 255,202 non-qualified 10 year options [Member]
Issuance of 255,202 non-qualified 10 year options
Issuance of 2,994,703 non-qualified 5-10 year options [Member]
Issuance of 2,994,703 non-qualified 5-10 year options [Member]
Issuance of 271,926 non-qualified 5-10 year options [Member]
Issuance of 271,926 non-qualified 5-10 year options [Member]
Issuance of 1,579,415 non-qualified 5-10 year options [Member]
Issuance of 1,579,415 non-qualified 5-10 year options
Unregistered Securities [Member]
Unregistered Securities
Registered Direct Offering and Outstanding Warrants [Member]
Registered Direct Offering and Outstanding Warrants
Issuance of 191,947 non-qualified 5-10 year options [Member]
Issuance of 211,303 non-qualified 5-10 year options
May 5, 2014 Stock Options Granted [Member]
May 5, 2014 Stock Options Granted
November 12, 2014 Offering [Member]
November 12, 2014 Offering
Issued to Investors on July 28, 2010 [Member]
Issued to Investors on July 28, 2010
Issued to Investors on October 25, 2013 [Member]
Issued to Investors on October 25, 2013
Issued to Investors on November 17, 2014 [Member]
Issued to Investors on November 17, 2014
2015 Short-Term Non-Qualified Option Grants [Member]
2015 Short-Term Non-Qualified Option Grants
2015 Long-Term Incentive Option Grants [Member]
2015 Long-Term Incentive Option Grants
Equity Purchase Agreement [Member]
ATM Offering [Member]
ATM Offering
Related Party Transactions, by Related Party [Axis]
Related Party [Domain]
Chief Executive Officer [Member]
Directors, Officers and Employees [Member]
Employees and Consultants [Member]
Employees and Consultants
Directors [Member]
Directors
Common Stock, Shares Authorized
Common Stock, Shares, Outstanding
Common stock reserved for issuance
Common stock reserved for issuance
Class of Warrant or Right, Outstanding
Number of options outstanding
Unvested Shares
Issued but unvested restricted stock
Issued but unvested restricted stock
Total stock and stock equivalents outstanding
Total stock and stock equivalents outstanding
Common Stock, Capital Shares Reserved for Future Issuance
Number of options vested and expected to vest outstanding
Stock option expense
Non-qualified stock options
Non-qualified stock options
Contractural lives
Lower Limit
Upper Limit
Aggregate intrinsic value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value
Unrecognized compensation costs
Unrecognized compensation costs
Expected compensation cost
Expected compensation cost
Weighted average recognition period
Weighted average recognition period
Restricted stock grants estimated forfeiture amount
Restricted stock grants estimated forfeiture amount
Share based compensation
Total fundraising limit
Total fundraising limit
Equity Issuance, Per Share Amount
Equity Issuance, Per Share Amount
Common Stock issued
Proceeds from Issuance of Common Stock
Common stock and warrants sold
Common stock and warrants sold
Common stock to be purchased in the Offering
Exercisable term
Shares of common stock to be purchased by fixed combination
Shares of common stock to be purchased by fixed combination
Purchase price of fixed combination
Purchase price of fixed combination
Warrant exercise price
Maximum common stock ownership to be eligible for exercise of warrants
Maximum common stock ownership to be eligible for exercise of warrants
Net proceeds from the Offering received after payments of fees and expenses
Net proceeds from the Offering received after payments of fees and expenses
Amount allocated from the Offering to common stock
Amount allocated from the Offering to warrants
Volitility rate
Risk-free interest rate
Dividend yield
Expected term
Strike Price
Strike Price
Stock options granted
Fair value of stock options granted
Fair value of stock options granted
Fair market value on measurement date
Fair market value on measurement date
Pre-vesting forfeiture rate
Pre-vesting forfeiture rate
Value of vested awards
Expected dividends
Stock options granted
Shares of Common Stock limit on stock options
Shares of Common Stock limit on stock options
Common stock, purchase commitment amount
Common stock, purchase commitment amount
Common stock purchase amount, per business day
Common stock purchase amount, per business day
Common stock purchase amount, per business day, value
Common stock purchase amount, per business day, value
Percentage of aggregate shares of the Company's common stock to be purchased
Percentage of aggregate shares of the Company's common stock to be purchased
Percentage of purchase price per share, pursuant to VWAP
Percentage of purchase price per share, pursuant to VWAP
Stock issued for compensation for commitment, shares
Stock issued for compensation for commitment, amount
Warrants Outstanding
Exercise price
Income (loss) from operations before income taxes
Net loss per share, basic and diluted
Warrant liability
Total liabilities
Additional paid in capital
Accumulated deficit
Total stockholders' equity
Numerator:
Numerator:
Denominator
Denominator
Weighted-average common shares outstanding
Trade payables
Accrued expenses and other
Accrued payroll liabilities
Total
Capitalized start up costs
Capitalized start up costs
Share based compensation
Share based compensation
Net operating loss carry-forward
Less: valuation allowance
Deferred Tax Assets, Net, Total
Tax benefit at U.S. federal statutory rate
State income taxes/(benefit) before valuation allowance, net of federal benefit
Warrant revaluation (income)/expense
Capitalized start-up costs
Stock-based compensation
Increase in valuation allowance
Total provision for income tax benefit
Calculated aggregate value
Weighted average exercise price per share of warrant
Weighted average exercise price per share of warrant
Closing price per share of common stock
Weighted average volatility
Weighted average remaining expected life (years)
Weighted average risk-free interest rate
Dividend yield
Beginning of Period
Weighted Average Exercise Price Beginning of the Year
Weighted Average Fair Value Stock Options Beginning of the Year
Weighted Average Exercise Price Stock Options Granted
Weighted Average Fair Value Stock Options Granted
Weighted Average Fair Value Stock Options Granted
Exercised
Weighted Average Exercise Price
Weighted Average Exercise Price
Weighted Average Fair Value Stock Options Exercised
Weighted Average Fair Value Stock Options Exercised
Forfeited
Weighted Average Exercise Price Stock Options Forfeited
Weighted Average Fair Value Stock Options Forfeited
Weighted Average Fair Value Stock Options Forfeited
Expired
Weighted Average Exercise Price Stock Options Expired
Weighted Average Fair Value Stock Options Expired
Weighted Average Fair Value Stock Options Expired
End of year
Weighted Average Exercise End of Year
Weighted Average Fair Value Stock Options End of Year
Weighted Average Fair Value Stock Options End of Year
Options exercisable
Weighted Average Exercise Price Options exercisable
Weighted Average Fair Value Options exerciseable
Weighted Average Fair Value Options exerciseable
Exercise Price Range [Axis]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]
Range 1 [Member]
Range 1
Range 2 [Member]
Range 2
Range 3 [Member]
Range 3
Range 4 [Member]
Range 4
Exercise price lower range limit
Exercise price upper range limit
Weighted Average Remaining Contractural Life - Years
Weighted Average Remaining Contractural Life - Years
Weighted Average Exercise Price Stock Options Outstanding
Number of Awards Vested
Weighted Average Exercise Price
Weighted Average Remaining Contractual Life of Stock Options Vested
Warrant [Member]
Warrant Amount
Average risk-free interest rate
Average expected life- years
Expected volatility
Expected dividends
Total awards outstanding beginning of the period
Weighted average grant date fair value total awards outstanding beginning of the period
Units granted
Weighted average grant date fair value units Granted
Units Exercised/Released
Units Exercised/Released
Weighted average grant date fair value units exercised/released
Weighted average grant date fair value units exercised/released
Units vested
Total units vested
Total units vested
Weighted average grant date fair value units Vested
Units Cancelled/Forfeited
Weighted average grant date fair value units Cancelled/Forfeited
Total awards outstanding at end of period
Total awards outstanding at end of period
Weighted Average Grant Date Fair value, Total awards outstanding at end of period
Weighted Average Grant Date Fair value, Total awards outstanding at end of period
Weighted average grant date fair value total units non-vested
Total units outstanding for the period
Total units outstanding for the period
Weighted average grant date fair value total units outstanding for the period
Weighted average grant date fair value total units outstanding for the period
Statement, Business Segments [Axis]
Segment [Domain]
Consulting [Member]
Consulting
Technology [Member]
Technology
Corporate and Eliminations [Member]
Corporate and Eliminations
Segment Reporting [Member]
Segment Reporting
Revenue
Total Assets
Property Additions
Interest Expense
Depreciation
Fair Value, Hierarchy [Axis]
Fair Value Hierarchy [Domain]
Quoted prices in active markets - Level 1 [Member]
Significant other observable inputs - Level 2 [Member]
Significant unobservable inputs - Level 3 [Member]
Assets:
Cash and cash equivalents
Liabilities:
Warrant liability
Balance, beginning of period
Issuance of additional warrants
Exercise of warrants
Change in fair value of warrant liability
Balance, end of period
Total Current Assets
Total Assets
Total Current Liabilities
Warrant liability
Total Liabilities
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity
Gross Margin
Total Operating Expenses
Operating Loss
Class Of Warrant Or Rights Revaluation
Total Other Income and (Expenses)
Net loss before income taxes
Net Income (Loss)
Unrealized gain (loss) on marketable securities
Accounts receivable - fees and reimbursable project costs
Prepaid expenses and other assets
Accounts payable and accrued liabilities (IncreaseDecreaseInAccountsPayableAndAccruedLiabilities)
Net Cash Used In Operating Activities
Payments for Patent costs
Net Cash Used In Investing Activities
Payments for Stock offering costs
Restricted cash (IncreaseDecreaseInRestrictedCash)
Net Cash Provided By Financing Activities
Net Decrease In Cash and Cash Equivalents
Cash Paid During The Period [Abstract]
Interest paid
Income taxes paid
Proceeds From The Sale Of Common Stock Net Of Offering Costs
Proceeds From The Sale Of Common Stock Net Of Offering Costs Shares
Shares Issued Registered Direct Offering Net Of Offering Costs
Shares Issued Registered Direct Offering Net Of Offering Costs Shares
Fair value of warrants issued with financing
Stock-based compensation
Stock-based compensation (Shares)
Stock Based Compensation And Payment Of Accrued Compensation
Stock Based Compensation And Payment Of Accrued Compensation Shares
Prepaid Expenses Other Current Assets [Text Block]
E N E C [Member]
Value Of Nuclear Science And Technology Centre
Power Output Increase Based On Future Potential Reveunes
Operating Cycle Length
Maximum Increase In Power Output Based On Future Revenue
Metallic Fuel Power Uprate Percentage
Operating Cycle Length Westinghouse Type
Federally insured cash limit
Restricted Cash (RestrictedCashAndInvestments)
Letter Of Credit
Marketable Securities (MarketableSecurities)
Percentage Of Cost Of Consulting From One Firm
Concentration Risk, Percentage
Amortization period for patents
Cumulative Effect
Portion Of Accounts Receivable
Major Customer Revenue Percentage
Prepaid Expense and Other Assets, Current
Security Deposit
Capitalized Costs For Patents
Investment in patents
Non-cash income
Fairfax County Complaint One [Member]
Fairfax County Complaint Two [Member]
Monthly rental fees
Compensatory damages sought
Task Order One With Texas Am University [Member]
Consulting Agreement Montly Payments
Amount due on December 15, 2012
Total amount of payments made
Amount due on delivery of the final report
Professional Services Agreement
Stockbased Compensation [Member]
Two Zero Zero Six Stock Plan [Member]
Two Zero One Five Equity Incentive Plan [Member]
Issuance Of Two Five Five Two Zero Two Nonqualified One Zero Year Options [Member]
Issuance Of Two Nine Nine Four Seven Zero Three Nonqualified Five One Zero Year Options [Member]
Issuance Of Two Seven One Nine Two Six Nonqualified Five One Zero Year Options [Member]
Issuance Of One Five Seven Nine Four One Five Nonqualified Five One Zero Year Options [Member]
Issuance Of One Nine One Nine Four Seven Nonqualified Five One Zero Year Options [Member]
May Five Two Zero One Four Stock Options Granted [Member]
November One Two Two Zero One Four Offering [Member]
Issued To Investors On July Two Eight Two Zero One Zero [Member]
Issued To Investors On October Two Five Two Zero One Three [Member]
Issued To Investors On November One Seven Two Zero One Four [Member]
Two Zero One Five Shortterm Nonqualified Option Grants [Member]
Two Zero One Five Longterm Incentive Option Grants [Member]
Class of Warrant or Right, Outstanding
Number of options outstanding
Unvested Shares
Number of options vested and expected to vest outstanding
Total Fundraising Limit
Equity Issuance Amount Per Share
Common Stock And Warrants Sold
Common stock to be purchased in the Offering
Exercisable term
Shares Of Common Stock To Be Purchased By Fixed Combination
Purchase Price Of Fixed Combination
Warrant exercise price
Maximum Common Stock Ownership To Be Eligible For Exercise Of Warrants
Net Proceeds From The Offering Received After Payments Of Fees And Expenses
Amount allocated from the Offering to common stock
Amount allocated from the Offering to warrants
Strike Price
Stock options granted
Share Based Compenation Weighted Average Fair Value
Fair Market Value On Measurement Date
Pre Vesting Forfeiture Rate
Value of vested awards
Expected dividends (FairValueAssumptionsExpectedDividendPayments)
Stock options granted (ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross)
Shares Of Common Stock Limit On Stock Options
Common Stock Purchase Commitment Amount
Common Stock Purchase Amount Per Business Day
Common Stock Purchase Amount Per Business Day Value
Percentage Of Aggregate Shares Of The Company S Common Stock To Be Purchased
Percentage Of Purchase Price Per Share Pursuant To Vwap
Stock issued for compensation for commitment, shares
Stock issued for compensation for commitment, amount
Numerator [Abstract]
Denominator [Abstract]
Deferred Tax Assets Share Based Compensation
Less: valuation allowance
Deferred Tax Assets, Net, Total
Tax benefit at U.S. federal statutory rate
State income taxes/(benefit) before valuation allowance, net of federal benefit
Warrant revaluation (income)/expense
Capitalized start-up costs
Stock-based compensation (IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost)
Increase in valuation allowance
Calculated aggregate value
Weighted Average Exercise Price Per Share Of Warrant
Closing price per share of common stock
Weighted average volatility
Weighted average remaining expected life (years)
Weighted average risk-free interest rate
Dividend yield
Weighted Average Exercise Price Beginning of the Year
Weighted Average Exercise Price Stock Options Granted
Share Based Compensation Weighted Average Fair Value Stock Options Granted
Exercised
Share Based Compensation Weighted Average Exercise Price Stock Options Exercised
Share Based Compensation Weighted Average Fair Value Stock Options Exercised
Forfeited
Weighted Average Exercise Price Stock Options Forfeited
Share Based Compensation Weighted Average Fair Value Stock Options Forfeited
Expired
Weighted Average Exercise Price Stock Options Expired
Share Based Compensation Weighted Average Fair Value Stock Options Expired
Share Based Compensation Weighted Average Fair Value End Of Year
Options exercisable
Weighted Average Exercise Price Options exercisable
Share Based Compensation Weighted Average Fair Value Options Exerciseable
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term
Weighted Average Exercise Price
Weighted Average Remaining Contractual Life of Stock Options Vested
Warrant Amount [Member]
Weighted average grant date fair value total awards outstanding beginning of the period
Weighted average grant date fair value units Granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fai
Share Based Compensation Arrangement By Share Based Paymant Award Equity Instruments Other Than Options Vested Total
Weighted average grant date fair value units Vested
Weighted average grant date fair value units Cancelled/Forfeited
Share Based Compensation Arrangement By Share Based Paymant Award Equity Instruments Other Than Options
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value Period
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Total Nonvested Number
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Total Nonvested Weighted Average Grant Date Fair Va
Assets:
Cash and cash equivalents (CashAndCashEquivalentsFairValueDisclosure)
Liabilities:
Warrant liability (DerivativeFairValueOfDerivativeNet)
Balance, beginning of period
Exercise of warrants
Change in fair value of warrant liability